Skip to content

RNTX RNTX Return on assets

Return on assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
8.1%+2.5pp
Gilead Sciences logo
Gilead SciencesGILD
16.4%+5.8pp
AbbVie logo
AbbVieABBV
2.7%-0.3pp
CTO
Citius Oncology, Inc.CTOR
-44.2%+10.6pp
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-79.2%+36.3pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
4.7%+2.4pp

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Calculated from RNTX’s reported figures.

Based on trailing twelve months.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's return on assets?
RNTX (RNTX) reported return on assets of -119.7% in Q1 2026.
How has RNTX's return on assets changed year-over-year?
RNTX's return on assets decreased by 53.1% year-over-year, from -78.1% to -119.7%.
What is the long-term trend for RNTX's return on assets?
Over 5 years (2020 to 2025), RNTX's return on assets has grown at a 3.2% compound annual growth rate (CAGR), from -98.5% to -115.5%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.